Cameron's Research Fund Gives $100,000 to Advance Ependymoma Research
The Cameron Corno Research Fund at the Lilabean Foundation is giving $100,000 to the Children's Brain Tumor Network (CBTN) to test a new immunotherapy for children whose ependymoma recurs.
What this gift supports
When ependymoma returns, children have very few treatments that work. This gift will advance a project led by Dr. Peter Madsen at Children's Hospital of Philadelphia (CHOP) to test a new CAR T cell therapy developed by Dr. Leyuan Ma.
CAR T therapy trains a patient's own immune cells to find and attack cancer. The team will first test Dr. Ma's CAR T cells on patient-derived ependymoma tumoroids: lab-grown models built from real children's tumors. If those results are promising, the next step is testing the approach in mouse models.
Because the tumoroids and the research infrastructure already exist through CHOP and CBTN, the team can start right away. They won't need to spend the first years building tools. They can go straight to the question families currently facing a diagnosis are asking, “Could this work for my child?”
Why every answer moves research forward
This project will show whether Dr. Ma's approach should advance toward treatment for recurrent ependymoma. Either outcome has value.
If the results are strong, the therapy moves a step closer to becoming a reliable treatment option for children facing recurrent ependymoma. If they reveal limits, researchers, doctors, and funders learn where not to spend precious time and money. That focus speeds progress toward safer, more effective treatments.
Cameron is still helping researchers today
Cameron's impact reaches beyond this gift. She was enrolled in CBTN from the day she was diagnosed, so the network captured clinical information across her entire journey, including data from her care.
Those de-identified data remain available to researchers and can help answer new questions for years to come. Some of Cameron's tissue samples also remain in the CBTN biobank. A single tissue donation can fuel many studies over time, from new types of data to research approaches that don't exist yet.
A research model grown from Cameron's tissue also exists at Children's National Hospital. The team is now exploring whether it could play a role in this project.
Thank you, Cam's Crew
This $100,000 gift was made possible because of you. Every birthday donation, every tribute gift and every shared post builds Cameron's Research Fund into a force for children facing ependymoma and continues Cameron’s impact.



